InvestorsHub Logo
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

Re: BTH post# 7695

Thursday, 05/05/2011 11:44:24 AM

Thursday, May 05, 2011 11:44:24 AM

Post# of 80490
Precisely, the biomarkers should allow ariad to target those pts who have mutations that are not likely to respond to Pfizer's Crizotinib. Thanks for clearing up any confusion.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.